Pfizer and BioNTech said Jan. 25 they have launched a clinical study evaluating the safety and efficacy of an omicron-specific COVID-19 vaccine candidate.
Read the full post on Becker's Hospital Review - Healthcare News
Pfizer launches trial for omicron-specific COVID-19 vaccine
